[Asia Economy Reporter Minji Lee] Medipartner Biotech announced on the 19th that it recorded an operating loss of 12,393.73 million KRW last year, an increase in the deficit compared to the previous year. Sales amounted to 7,760.39 million KRW, a 79% decrease from one year earlier, and the net loss widened to 21,695.63 million KRW.



The company stated, "Sales decreased due to the sale of consolidated subsidiaries," and added, "Building rental costs increased due to entry into new business areas."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing